Skip to main content
. Author manuscript; available in PMC: 2021 Mar 6.
Published in final edited form as: Leukemia. 2020 Jun 18;35(3):850–862. doi: 10.1038/s41375-020-0922-x

Figure 5. Chimerism patterns after haplo-dCBT in patients with no myeloid bridge and sustained CB engraftment (Group 3, n = 21).

Figure 5.

Whole blood chimerism analysis (Figure 5A) revealed that the majority of Group 3 patients had either no or minimal haplo-identical donor engraftment (day 14 median chimerism 10%, range 0–94%) and the dominant CB unit pre-dominated thereafter. The dominant CB unit was either the only or greatest contributor to myeloid (Figure 5B) and T-cell (Figure 5C) lineages at day 28 and beyond.

*Footnote: Red: Haplo-identical donor; Blue: Dominant (engrafting) CB unit; Green: Non-dominant (non-engrafting) unit